Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-004205
- form_type
- 8-K
- ticker
- CHRN
- cik
- 0001549084
- company_name
- EKSO BIONICS HOLDINGS, INC.
- filed_at
- 2026-02-17T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:35.396410+00:00
- generated_at
- 2026-05-16T02:25:07.098397+00:00
- sec_items
- ["1.01", "2.02", "3.02", "3.03", "5.03", "5.01", "5.02", "9.01"]
- event_type
- m_and_a
- sentiment
- negative
- materiality_score
- 0.95
- calibrated_materiality_score
- 0.95
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-004205
- json_url
- https://secwatch.observer/filing/0001437749-26-004205.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-004205.md
- text_url
- https://secwatch.observer/filing/0001437749-26-004205.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1549084/000143774926004205/0001437749-26-004205-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1549084/000143774926004205/ekso20260216_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Source-grounded claims
2986156314b8fbb020ad996a15c35c3604eb0e10
EKSO BIONICS HOLDINGS, INC.: Board approved Second Restated Articles, effective upon Closing, increasing authorized common shares from 141,428,571 to 290,000,000 and making other changes (effective 2026-02-14).
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
49078d2f8b5e9803e28be61dd94ad207d7d3d3aa
EKSO BIONICS HOLDINGS, INC.: Amendment No. 1 to Bylaws removes prohibition on stockholder action by written consent and revises record date provision to clarify applicability to meetings only (effective 2026-02-14).
On February 14, 2026, the Board adopted an amendment (“Amendment No. 1”) to the Company’s amended and restated by-laws (the “Bylaws”) to align certain provisions of the Bylaws with Nevada law by (i) removing the provision of the Bylaws prohibiting stockholder action by written consent, and (ii) revising the record date provision to clarify that such provision is only applicable to meetings of stockholders.
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
be9a731ac3b8e291ab171cbe2b568086f4542007
EKSO BIONICS HOLDINGS, INC.: Second Restated Bylaws introduce new provisions effective upon Closing, including quorum requirements, written consent rules, board quorum, amendment provisions, and no cumulative voting (effective 2026-02-14).
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
SEC evidence
c75f22391fc4b9229c83280fd4e2b6c4a3b25b5c
EKSO BIONICS HOLDINGS, INC. entered into Contribution and Exchange Agreement with APLD Intermediate HoldCo LLC, APLD ChronoScale HoldCo LLC, and Applied Digital Cloud Corporation (effective 2026-02-15).
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
SEC 8-K Item 1.01/1.02
confidence 0.9
SEC evidence
Comparable filings
Enviri II Corp
New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA
Enviri II Corp
June 1, 2026, 5:18 PM ET
m_and_a
Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 3.03, 5.01, 5.02, 5.03, 9.01
same event type: m_and_a
similar materiality
This filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
Comparable filing
In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.
Filing page
SEC filing
EWCZ
European Wax Center completes take-private by General Atlantic at $5.80/share; stock delisted
European Wax Center, Inc.
May 8, 2026, 7:59 PM ET
m_and_a
Items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.02, 5.03, 5.01, 8.01, 9.01
same fact type: material_agreement
same SEC item: 1.01, 3.03, 5.01, 5.02, 5.03, 9.01
same event type: m_and_a
similar materiality
This filing
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
Comparable filing
As previously disclosed, European Wax Center, Inc., a Delaware corporation (the “ Company ”), entered into an Agreement and Plan of Merger, dated as of February 9, 2026 (the “ Merger Agreement ”), by and among Glow Midco, LLC, a Delaware limited liability company (“ Parent ”), Glow Merger Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub Inc. ”), Glow Merger Sub 2, LLC, a Delaware limited liability company and a wholly owned subsidiary of Parent (“ Merger Sub LLC ,” and together with Merger Sub Inc., the “ Merger Subs ”) and EWC Ventures, LLC, a Delaware limited liability company (“ Opco ”), pursuant to which (i) Merger Sub Inc. merged with and into the Company (the “ Corporate Merger ”), with the Company surviving the Corporate Merger as the surviving corporation (the “ Surviving Corporation ”) and a wholly owned subsidiary of Parent and (ii) Merger Sub LLC merged with and into Opco, with Opco surviving as the surviving limited liability company
Filing page
SEC filing
APAD
Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M
Enhanced Group Inc.
May 8, 2026, 7:59 PM ET
m_and_a
Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01
same fact type: governance_change
same SEC item: 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 9.01
same event type: m_and_a
similar materiality
This filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
Comparable filing
As a result of the Business Combination, the Company ceased being a shell company
Filing page
SEC filing
CTLP
Cantaloupe completes merger with 365 Retail Markets; shareholders receive $11.20/share
CANTALOUPE, INC.
May 8, 2026, 7:59 PM ET
m_and_a
Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01
same fact type: material_agreement
same SEC item: 3.03, 5.01, 5.02, 9.01
same event type: m_and_a
similar materiality
This filing
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
Comparable filing
the Company terminated and repaid in full all outstanding obligations due under the Second Amended and Restated Credit Agreement, dated as of January 31, 2025, by and among, inter alios , the Company, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “ Credit Agreement ”).
Filing page
SEC filing
CTRA
Coterra Energy completes merger with Devon; shares converted at 0.70x ratio
Coterra Energy Inc.
May 7, 2026, 7:59 PM ET
m_and_a
Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 9.01
same fact type: material_agreement
same SEC item: 3.03, 5.01, 5.02, 9.01
same event type: m_and_a
similar materiality
This filing
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
Comparable filing
on the Closing Date, the Company terminated all outstanding lender commitments under the Credit Agreement, dated as of March 10, 2023 (as amended by Amendment No. 1, dated as of September 12, 2024, and as further amended, restated, supplemented or modified prior to the Closing Date, the “Credit Agreement”), among the Company, the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent
Filing page
SEC filing
CPRX
Angelini Pharma to acquire Catalyst Pharma for $4.1B ($31.50/share), premium 28% to VWAP
CATALYST PHARMACEUTICALS, INC.
May 7, 2026, 7:59 PM ET
m_and_a
Items 1.01, 5.03, 7.01, 8.01, 9.01
same fact type: governance_change, material_agreement
same SEC item: 1.01, 5.03, 9.01
same event type: m_and_a
similar materiality
This filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
Comparable filing
On May 6, 2026, the Board of Directors approved and adopted an amendment (the “ Forum Selection Amendment ”) to the Company’s existing By-Laws that amends Article VIII, Section 8.1 of the By-Laws of the Company.
Filing page
SEC filing
NVRI
Enviri completes sale of Clean Earth to Veolia for $3.04B; spins off remaining businesses as New Enviri
ENVIRI Corp
June 1, 2026, 5:15 PM ET
m_and_a
Items 1.02, 2.01, 3.01, 3.03, 5.01, 9.01
same fact type: material_agreement
same SEC item: 3.03, 5.01, 9.01
same event type: m_and_a
similar materiality
This filing
On February 15, 2026, Ekso Bionics Holdings, Inc., a Nevada corporation (“Ekso” or the “Company”), entered into a Contribution and Exchange Agreement (the “Contribution and Exchange Agreement”) with APLD Intermediate HoldCo LLC, a Delaware limited liability company (“APLD Intermediate”), APLD ChronoScale HoldCo LLC, a Delaware limited liability company and a wholly owned subsidiary of APLD Intermediate (“Contributor”), each a wholly owned direct or indirect subsidiary of Applied Digital Corporation, a Nevada corporation (“APLD”), and Applied Digital Cloud Corporation, a Nevada corporation, which at the time of the Closing (as defined below), will be a wholly owned subsidiary of Contributor (“Cloud”)
Comparable filing
On June 1, 2026, in connection with the Transactions, Enviri repaid all amounts owing under that certain Receivables Purchase Agreement, dated as of June 24, 2022 (as amended, restated, supplemented or otherwise modified from time to time, the “AR Facility”), among Harsco Receivables LLC, Enviri, the purchasers party thereto, and PNC Bank, National Association, as agent, and terminated all other documents entered into in connection therewith.
Filing page
SEC filing
DVN
Devon completes all-stock merger with Coterra; combined company retains DVN ticker
DEVON ENERGY CORP/DE
May 7, 2026, 7:59 PM ET
m_and_a
Items 2.01, 5.02, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.02, 5.03, 9.01
same event type: m_and_a
similar materiality
This filing
On February 14, 2026, the Board approved the Second Restated Articles, which will only become effective immediately prior to the Closing, subject to stockholder approval, and the Second Amended and Restated Bylaws (the “Second Restated Bylaws”), which will only become effective upon the Closing.
Comparable filing
On May 7, 2026, the Company filed an amendment to the Company’s restated certificate of incorporation (the “ Authorized Share Charter Amendment ”), effective as of such date, increasing the number of authorized shares of Company Common Stock from 1,000,000,000 to 2,000,000,000.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.